Respiratory drugs devices market size was estimated to USD 62,035 million in 2018 and expected to grow at a CAGR of 7% for the forecasted period of 2018-2023. The market is driven by the growing prevalence of respiratory diseases and disorders. There is been constant growth in the number of cases of asthma and COPD. Asthma and COPD account for approximately 60% of the respiratory drugs and devices market. An aging population and major lifestyle changes have led to a rise in respiratory diseases.
Please read the originial post here: https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market